Sample Size Calculations for Controlled Clinical Trials Using Generalized Estimating Equations (GEE)

Summary

Objectives: Clinical trials with correlated response data based on generalized estimating equations (GEE) have become increasingly popular as they require smaller samples than classical methods that ignore the clustered nature of the data. We have recently derived the recommendation to use the independence estimating equations (IEE) as primary analysis in most controlled clinical trials instead of GEE with estimated correlations [1]. Although several approaches for sample size and power calculation have been proposed, we have shown that most of these procedures are very specific and not as general as required for designing clinical trials.

Methods: We extended the previously developed SAS macro GEESIZE to overcome this restriction. Specifically, we have added the option of an independence working correlation matrix required for the IEE. Additionally, we have reformulated the hypotheses to allow for coding that includes an intercept term instead of the previously used analysis of variance coding.

Results: To demonstrate the validity of GEESIZE we investigate the calculated sample sizes for specific models where closed formulae are available. For illustration, we utilize GEESIZE for planning a new trial on the treatment of hypertension and thereby exemplify its flexibility.

Conclusions: We show that our freely available macro is a very general and useful tool for sample size calculation purposes in clinical trials with correlated data.

Keywords

Sample size calculation - controlled clinical trials - generalized estimating equations - SAS software

• References

• 1 Dahmen G, Ziegler A. Generalized estimating equation on controlled clinical trials: hypotheses testing. Biom J 2004; 46 (01) 214-32.
• 2 Davis CS. Statistical methods for the analysis of repeated measurements. New York: Springer; 2002
• 3 Rochon J. Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med 1998; 17 (14) 1643-58.
• 4 Pan W. Sample size and power calculations with correlated binary data. Control Clin Trials 2001; 22 (03) 211-27.
• 5 Jung SH, Ahn C. Sample size estimation for GEE method for comparing slopes in repeated measurements data. Stat Med 2003; 22 (08) 1305-15.
• 6 Ziegler A, Kastner C, Blettner M. The generalised estimating equations: an annotated bibliography. Biom J 1998; 40 (02) 115-39.
• 7 Muñoz A, Carey V, Schouten JP, Segal M, Rosner B. A parametric family of correlation structures for the analysis of longitudinal data. Biometrics 1992; 48 (03) 733-42.
• 8 Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics 1994; 50 (01) 270-8.
• 9 Liu G, Liang KY. Sample size calculations for studies with correlated observations. Biometrics 1997; 53 (03) 937-47.
• 10 Yi Q, Panzarella T. Estimating sample size for tests on trends across repeated measurements with missing data based on the interaction term in a mixed model. Control Clin Trials 2002; 23 (05) 481-96.
• 11 Hall S, Prescott RI, Hallman RJ, Dixon S, Harvey RE, Ball SG. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension. J Cardiovasc Pharmacol 1991; 18 Suppl (Suppl. 04) S35-8.